Robotic Total Pelvic Exenteration with Laparoscopic Rectus Flap: Initial Experience

Table 2

Operative characteristics and hospital course of robotic total pelvic exenteration with laparoscopic rectus flap (MITPE) versus open patients.

	MITPE; Case 1	MITPE; Case 2	MITPE; Case 3	Open TPE (9); median (range)
Operative time (hours)	11	10	9.5	11.5^†; (8–14)
Rectus flap? (Yes/No)	Y	Y	Y	6; (66.7%)
Estimated blood loss (cc)^*	800	500	350	2300; (950–6100)
	Infused narcotics (mg)
Epidural use	None	None	5	4.5; (2–8)
PCA use	5	1	25.2	5^‡; (1–14)
	IV morphine equivalents (mg)
Overall narcotic usage	176.2	8.3	114.8	232.7; (34.8–3368.3)
	Mean = 99.8 (85)			Mean = 961.1 (1350)
	Other analgesic usage (mg)
Ketorolac	240	None	None	75; (1 pt.)
Tylenol	650	16,900	14,000	1950; (650–16,250)
Others	None	None	Celecoxib 400; gabapentin 300	Ibuprofen 3600; (1800–3600, 3 )
	Disposition
ICU stay (POD)^*	1	1	1	3; (2–14)
Discharge (POD)^*	7	8	7	13; (8–17)

Median values for each parameter are shown with range or percentages in parentheses, unless otherwise labeled. Labeled means are shown with standard deviation (SD). Medication use pertains to in-hospital stay only. Narcotic use includes hydromorphone, oxycodone, oxycontin, and morphine converted to morphine equivalents and summed for comparison. MITPE: robotic total pelvic exenteration with laparoscopic rectus flap; TPE: total pelvic exenteration; POD: postoperative day; PCA: patient controlled analgesia; ICU: intensive care unit; cc: cubic centimeters.
^*Statistically significant difference between MITPE and open TPE groups ().
^†OR times available for 8 of 9 open TPE patients.
^‡Two open exenteration patients were managed postoperatively with PCEA (patient controlled epidural analgesia) and therefore separate PCA use and total narcotic use relative to this was unavailable.
Pts: number of patients in cohort who used this during hospital stay.